Press Release

ProJenX Announces Formation of Scientific Advisory Board

AVILAR THERAPEUTICS INCREASES FINANCING TO $75 MILLION TO ADVANCE PIPELINE OF NOVEL EXTRACELLULAR PROTEIN DEGRADERS

Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009

Aspen Neuroscience Inks $40 Million Debt Deal with Silicon Valley Bank

Multi-omics Startup Pleno Inc. Continues to Strengthen its Board of Directors

Multi-omics Startup Pleno Inc. Expands Leadership Team to Accelerate Development of its Novel Hypercoding Technology

CMC Expert Kim Raineri Joins Aspen Neuroscience as Chief Technology Officer

Multi-omics Startup Pleno Inc. Announces $40 Million in Series A Funding Led by Deerfield Management with Participation by Foresite Capital

Immunitas Therapeutics to Present Preclinical Data on IMT-009 at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies